A single blood draw added to routine cancer screenings found roughly seven times more cancers than standard tests alone, ...

The Phase I/II China-based trial will test the combination in patients with PD-L1-positive, EGFR mutated tumors.

To participate, submit your response here by July 10 at 9 a.m. Eastern. This week’s winners will be announced by July 22. By The Learning Network Heeva Alavi, an Iranian-American, writes about her ...

The plaintiff’s deposition is rarely just another deposition. The plaintiff is the architect of the lawsuit, the person whose factual story drives ...

When Vaibhav Bhaskar was in fifth grade, his teacher asked the class to come up with alliterations to put on their name tags: ...

Millions of people taking semaglutide or tirzepatide for weight loss could be losing more than fat. A pharmacovigilance study ...

Introduction In 2021, globally, cardiometabolic diseases (CMDs) accounted for 35% of the 1.73 billion disability-adjusted life years (DALYs) attributed to non-communicable diseases. The Healthy Life ...

Donald Trump's uneven walk towards Marine One in North Dakota has reignited questions about the 80-year-old president's ...

Could a common over-the-counter anti-inflammatory drug become a new weapon against drug-resistant tuberculosis? Early findings suggest immune benefits, but larger trials are needed to determine ...

An ex-US Army soldier accused of fatally shooting his wife and covering up her death was stony-faced inside an Alaska ...

The judgement of the Federal High Court in Abuja directing the deregistration of five political parties has again exposed the ...

SKY-0515 is a daily oral drug designed to lower both huntingtin, the protein that drives HD, and PMS1, a DNA repair protein linked to somatic CAG repeat expansion. Researchers hope this dual-target ...